
### [MONDO:0005170](http://purl.obolibrary.org/obo/MONDO_0005170)
**Label:** myeloid neoplasm

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0017893](http://purl.obolibrary.org/obo/MONDO_0017893) (inherited acute myeloid leukemia), [MONDO:0012883](http://purl.obolibrary.org/obo/MONDO_0012883) (acute promyelocytic leukemia), [MONDO:0017894](http://purl.obolibrary.org/obo/MONDO_0017894) (acute myeloid leukemia with CEBPA somatic mutations), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0005029](http://purl.obolibrary.org/obo/MONDO_0005029) (essential thrombocythemia), [MONDO:0005224](http://purl.obolibrary.org/obo/MONDO_0005224) (acute myeloblastic leukemia without maturation), [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), [MONDO:0010301](http://purl.obolibrary.org/obo/MONDO_0010301) (THCYTX), [MONDO:0017817](http://purl.obolibrary.org/obo/MONDO_0017817) (primary localized amyloidosis), [MONDO:0017816](http://purl.obolibrary.org/obo/MONDO_0017816) (primary systemic amyloidosis), [MONDO:0015558](http://purl.obolibrary.org/obo/MONDO_0015558) (isolated bone marrow mastocytosis), [MONDO:0015557](http://purl.obolibrary.org/obo/MONDO_0015557) (Smouldering systemic mastocytosis), [MONDO:0011118](http://purl.obolibrary.org/obo/MONDO_0011118) (bilineal acute myeloid leukemia), [MONDO:0017858](http://purl.obolibrary.org/obo/MONDO_0017858) (acute erythroid leukemia), [MONDO:0019025](http://purl.obolibrary.org/obo/MONDO_0019025) (extracutaneous mastocytoma), [MONDO:0018256](http://purl.obolibrary.org/obo/MONDO_0018256) (acute myeloid leukemia with t(8;16)(p11;p13) translocation), [MONDO:0020331](http://purl.obolibrary.org/obo/MONDO_0020331) (indolent systemic mastocytosis), [MONDO:0019460](http://purl.obolibrary.org/obo/MONDO_0019460) (acute leukemia of ambiguous lineage), [MONDO:0007896](http://purl.obolibrary.org/obo/MONDO_0007896) (acute monocytic leukemia), [MONDO:0011908](http://purl.obolibrary.org/obo/MONDO_0011908) (juvenile myelomonocytic leukemia), [MONDO:0007573](http://purl.obolibrary.org/obo/MONDO_0007573) (acute erythroleukemia, familial), [MONDO:0005272](http://purl.obolibrary.org/obo/MONDO_0005272) (refractory anemia), [MONDO:0015667](http://purl.obolibrary.org/obo/MONDO_0015667) (unclassified acute myeloid leukemia), [MONDO:0020526](http://purl.obolibrary.org/obo/MONDO_0020526) (acute megakaryoblastic leukemia in down syndrome), [MONDO:0008040](http://purl.obolibrary.org/obo/MONDO_0008040) (transient myeloproliferative syndrome (disease)), [MONDO:0011173](http://purl.obolibrary.org/obo/MONDO_0011173) (thrombocythemia 2), [MONDO:0013794](http://purl.obolibrary.org/obo/MONDO_0013794) (thrombocythemia 3), [MONDO:0019458](http://purl.obolibrary.org/obo/MONDO_0019458) (acute basophilic leukemia), [MONDO:0017833](http://purl.obolibrary.org/obo/MONDO_0017833) (primary hypereosinophilic syndrome), [MONDO:0009692](http://purl.obolibrary.org/obo/MONDO_0009692) (primary myelofibrosis), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0009891](http://purl.obolibrary.org/obo/MONDO_0009891) (polycythemia vera), [MONDO:0019456](http://purl.obolibrary.org/obo/MONDO_0019456) (acute myeloid leukemia with multilineage dysplasia), [MONDO:0018004](http://purl.obolibrary.org/obo/MONDO_0018004) (acute megakaryoblastic leukemia without down syndrome), [MONDO:0019457](http://purl.obolibrary.org/obo/MONDO_0019457) (Therapy related acute myeloid leukemia and myelodysplastic syndrome), [MONDO:0019454](http://purl.obolibrary.org/obo/MONDO_0019454) (refractory anemia with excess blasts), [MONDO:0019455](http://purl.obolibrary.org/obo/MONDO_0019455) (acute panmyelosis with myelofibrosis), [MONDO:0020320](http://purl.obolibrary.org/obo/MONDO_0020320) (acute myeloblastic leukemia with maturation), [MONDO:0019452](http://purl.obolibrary.org/obo/MONDO_0019452) (chronic myeloproliferative disease, unclassifiable), [MONDO:0020321](http://purl.obolibrary.org/obo/MONDO_0020321) (acute undifferentiated leukemia), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0020322](http://purl.obolibrary.org/obo/MONDO_0020322) (acute biphenotypic leukemia), [MONDO:0019451](http://purl.obolibrary.org/obo/MONDO_0019451) (chronic neutrophilic leukemia), [MONDO:0007546](http://purl.obolibrary.org/obo/MONDO_0007546) (myeloproliferative disorder, chronic, with eosinophilia), [MONDO:0010809](http://purl.obolibrary.org/obo/MONDO_0010809) (familial chronic myelocytic leukemia-like syndrome), [MONDO:0011895](http://purl.obolibrary.org/obo/MONDO_0011895) (idiopathic hypereosinophilic syndrome), [MONDO:0017835](http://purl.obolibrary.org/obo/MONDO_0017835) (lymphocytic hypereosinophilic syndrome), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), [MONDO:0018437](http://purl.obolibrary.org/obo/MONDO_0018437) (acute myeloid leukemia with NPM1 somatic mutations), [MONDO:0020317](http://purl.obolibrary.org/obo/MONDO_0020317) (acute myeloid leukemia with 11q23 abnormalities), [MONDO:0020318](http://purl.obolibrary.org/obo/MONDO_0020318) (acute myeloid leukemia with minimal differentiation), [MONDO:0018435](http://purl.obolibrary.org/obo/MONDO_0018435) (acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)), [MONDO:0018436](http://purl.obolibrary.org/obo/MONDO_0018436) (megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)), [MONDO:0015687](http://purl.obolibrary.org/obo/MONDO_0015687) (chronic eosinophilic leukemia), [MONDO:0015164](http://purl.obolibrary.org/obo/MONDO_0015164) (acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent), [MONDO:0018433](http://purl.obolibrary.org/obo/MONDO_0018433) (acute myeloid leukemia with t(6;9)(p23;q34)), [MONDO:0018874](http://purl.obolibrary.org/obo/MONDO_0018874) (acute myeloid leukemia), [MONDO:0015165](http://purl.obolibrary.org/obo/MONDO_0015165) (acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor), [MONDO:0018434](http://purl.obolibrary.org/obo/MONDO_0018434) (acute myeloid leukemia with t(9;11)(p22;q23)), [MONDO:0015166](http://purl.obolibrary.org/obo/MONDO_0015166) (acute myeloid leukemia with t(8;21)(q22;q22) translocation), [MONDO:0018871](http://purl.obolibrary.org/obo/MONDO_0018871) (acute myelomonocytic leukemia M4), [MONDO:0018872](http://purl.obolibrary.org/obo/MONDO_0018872) (acute megakaryoblastic leukemia), [MONDO:0020078](http://purl.obolibrary.org/obo/MONDO_0020078) (acute myeloid leukemia with recurrent genetic anomaly), [MONDO:0008554](http://purl.obolibrary.org/obo/MONDO_0008554) (thrombocythemia 1), [MONDO:0015040](http://purl.obolibrary.org/obo/MONDO_0015040) (refractory anemia with excess blasts type 1), [MONDO:0015041](http://purl.obolibrary.org/obo/MONDO_0015041) (refractory anemia with excess blasts type 2), [MONDO:0020312](http://purl.obolibrary.org/obo/MONDO_0020312) (atypical chronic myeloid leukemia), [MONDO:0020316](http://purl.obolibrary.org/obo/MONDO_0020316) (acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)), [MONDO:0006861](http://purl.obolibrary.org/obo/MONDO_0006861) (myeloid sarcoma), [MONDO:0020076](http://purl.obolibrary.org/obo/MONDO_0020076) (myeloproliferative neoplasm), [MONDO:0014837](http://purl.obolibrary.org/obo/MONDO_0014837) (hereditary thrombocytopenia with early-onset myelofibrosis), [MONDO:0015608](http://purl.obolibrary.org/obo/MONDO_0015608) (acute myeloid leukemia and myelodysplastic syndromes related to radiation), [MONDO:0013667](http://purl.obolibrary.org/obo/MONDO_0013667) (myelodysplastic syndrome), 

**Corr. equiv. classes:** [Orphanet:86839](http://www.orpha.net/ORDO/Orphanet_86839), [Orphanet:520](http://www.orpha.net/ORDO/Orphanet_520), [Orphanet:102379](http://www.orpha.net/ORDO/Orphanet_102379), [Orphanet:158778](http://www.orpha.net/ORDO/Orphanet_158778), [OMIM:151380](http://purl.obolibrary.org/obo/OMIM_151380), [Orphanet:86834](http://www.orpha.net/ORDO/Orphanet_86834), [Orphanet:158775](http://www.orpha.net/ORDO/Orphanet_158775), [Orphanet:86830](http://www.orpha.net/ORDO/Orphanet_86830), [Orphanet:329469](http://www.orpha.net/ORDO/Orphanet_329469), [OMIM:612376](http://purl.obolibrary.org/obo/OMIM_612376), [Orphanet:3318](http://www.orpha.net/ORDO/Orphanet_3318), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519), [Orphanet:518](http://www.orpha.net/ORDO/Orphanet_518), [OMIM:616937](http://purl.obolibrary.org/obo/OMIM_616937), [Orphanet:514](http://www.orpha.net/ORDO/Orphanet_514), [Orphanet:168940](http://www.orpha.net/ORDO/Orphanet_168940), [Orphanet:517](http://www.orpha.net/ORDO/Orphanet_517), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [Orphanet:318](http://www.orpha.net/ORDO/Orphanet_318), [Orphanet:319465](http://www.orpha.net/ORDO/Orphanet_319465), [Orphanet:71493](http://www.orpha.net/ORDO/Orphanet_71493), [Orphanet:314970](http://www.orpha.net/ORDO/Orphanet_314970), [Orphanet:480851](http://www.orpha.net/ORDO/Orphanet_480851), [Orphanet:86829](http://www.orpha.net/ORDO/Orphanet_86829), [Orphanet:3260](http://www.orpha.net/ORDO/Orphanet_3260), [OMIM:300331](http://purl.obolibrary.org/obo/OMIM_300331), [Orphanet:100020](http://www.orpha.net/ORDO/Orphanet_100020), [OMIM:601626](http://purl.obolibrary.org/obo/OMIM_601626), [OMIM:614286](http://purl.obolibrary.org/obo/OMIM_614286), [Orphanet:102724](http://www.orpha.net/ORDO/Orphanet_102724), [OMIM:254450](http://purl.obolibrary.org/obo/OMIM_254450), [OMIM:614521](http://purl.obolibrary.org/obo/OMIM_614521), [Orphanet:98848](http://www.orpha.net/ORDO/Orphanet_98848), [Orphanet:420611](http://www.orpha.net/ORDO/Orphanet_420611), [Orphanet:168956](http://www.orpha.net/ORDO/Orphanet_168956), [OMIM:607685](http://purl.obolibrary.org/obo/OMIM_607685), [Orphanet:824](http://www.orpha.net/ORDO/Orphanet_824), [Orphanet:314962](http://www.orpha.net/ORDO/Orphanet_314962), [OMIM:187950](http://purl.obolibrary.org/obo/OMIM_187950), [Orphanet:402014](http://www.orpha.net/ORDO/Orphanet_402014), [Orphanet:402017](http://www.orpha.net/ORDO/Orphanet_402017), [OMIM:601977](http://purl.obolibrary.org/obo/OMIM_601977), [Orphanet:86850](http://www.orpha.net/ORDO/Orphanet_86850), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:86851](http://www.orpha.net/ORDO/Orphanet_86851), [Orphanet:100019](http://www.orpha.net/ORDO/Orphanet_100019), [Orphanet:98836](http://www.orpha.net/ORDO/Orphanet_98836), [Orphanet:319480](http://www.orpha.net/ORDO/Orphanet_319480), [Orphanet:98837](http://www.orpha.net/ORDO/Orphanet_98837), [Orphanet:167714](http://www.orpha.net/ORDO/Orphanet_167714), [OMIM:600080](http://purl.obolibrary.org/obo/OMIM_600080), [Orphanet:98832](http://www.orpha.net/ORDO/Orphanet_98832), [Orphanet:98833](http://www.orpha.net/ORDO/Orphanet_98833), [Orphanet:98834](http://www.orpha.net/ORDO/Orphanet_98834), [Orphanet:98835](http://www.orpha.net/ORDO/Orphanet_98835), [Orphanet:370026](http://www.orpha.net/ORDO/Orphanet_370026), [Orphanet:99887](http://www.orpha.net/ORDO/Orphanet_99887), [Orphanet:98831](http://www.orpha.net/ORDO/Orphanet_98831), [Orphanet:314950](http://www.orpha.net/ORDO/Orphanet_314950), [OMIM:159595](http://purl.obolibrary.org/obo/OMIM_159595), [Orphanet:98274](http://www.orpha.net/ORDO/Orphanet_98274), [Orphanet:402026](http://www.orpha.net/ORDO/Orphanet_402026), [Orphanet:98277](http://www.orpha.net/ORDO/Orphanet_98277), [Orphanet:86846](http://www.orpha.net/ORDO/Orphanet_86846), [OMIM:133180](http://purl.obolibrary.org/obo/OMIM_133180), [Orphanet:86849](http://www.orpha.net/ORDO/Orphanet_86849), [OMIM:263300](http://purl.obolibrary.org/obo/OMIM_263300), [Orphanet:86843](http://www.orpha.net/ORDO/Orphanet_86843), [Orphanet:86845](http://www.orpha.net/ORDO/Orphanet_86845), [Orphanet:164726](http://www.orpha.net/ORDO/Orphanet_164726), [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [OMIM:131440](http://purl.obolibrary.org/obo/OMIM_131440), [Orphanet:66662](http://www.orpha.net/ORDO/Orphanet_66662), [Orphanet:98829](http://www.orpha.net/ORDO/Orphanet_98829), [Orphanet:314709](http://www.orpha.net/ORDO/Orphanet_314709), [Orphanet:98826](http://www.orpha.net/ORDO/Orphanet_98826), [Orphanet:729](http://www.orpha.net/ORDO/Orphanet_729), [Orphanet:102381](http://www.orpha.net/ORDO/Orphanet_102381), [OMIM:607785](http://purl.obolibrary.org/obo/OMIM_607785), [Orphanet:98824](http://www.orpha.net/ORDO/Orphanet_98824), [Orphanet:314701](http://www.orpha.net/ORDO/Orphanet_314701), [Orphanet:402023](http://www.orpha.net/ORDO/Orphanet_402023), [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521), [Orphanet:402020](http://www.orpha.net/ORDO/Orphanet_402020), 

**Class expressions from DL-Learner:**

- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 21.26%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 21.26%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 21.25%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 21.25%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 21.25%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 21.25%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 21.25%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 21.25%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 21.25%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 21.25%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 20.79%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 18.31%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 17.90%
- Thing 17.88%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 17.88%


